Zymeworks Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Zymeworks Inc. now
Current reporting with the operating signal separated from the noise.
Here's Why Zymeworks Inc. Paid $929 Million For Theravance Biopharma
The development tests whether Zymeworks Inc. can turn product investment into adoption, revenue and durable advantage.
Watch next: confirmation in a company filing, official release or regulator record.Zymeworks Inc.: Zymeworks to Acquire Theravance Biopharma, Inc.
The story matters when it changes Zymeworks Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Zymeworks Inc. (ZYME) Q1 2026 Earnings Call Transcript
Investors are testing whether Zymeworks Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Zymeworks Inc. (ZYME) reports Q1 loss, misses revenue estimates
Investors are testing whether Zymeworks Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Zymeworks Inc. Presents Promising Preclinical Data on Antibody-Drug Conjugates and T Cell Engagers at AACR Annual Meeting 2025
The story matters when it changes Zymeworks Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Zymeworks Inc. Appoints Oleg Nodelman to Board of Directors as Part of Ongoing Board Renewal Process
The story matters when it changes Zymeworks Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest ZYME filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Zymeworks Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →